Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies

BACKGROUND: The pan-immune-inflammation value (PIV) has been reported as a promising prognostic biomarker in multiple cancers but still remains inconclusive. The objective of this study is to systematically investigate the association of the pretreatment PIV with survival outcomes in cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hai-Jing, Yu, Shan, Ren, Jie-Qiong, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577316/
https://www.ncbi.nlm.nih.gov/pubmed/37850085
http://dx.doi.org/10.3389/fnut.2023.1259929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577316/
https://www.ncbi.nlm.nih.gov/pubmed/37850085
http://dx.doi.org/10.3389/fnut.2023.1259929

Ejemplares similares